More articles from Review
- Chemoprevention of colorectal cancer: Slow, steady progress
We are learning how to use aspirin and other drugs to prevent colorectal cancer, or at least reduce its incidence.
- Penicillin allergy: Consider trying penicillin again
With skin testing and, in some cases, desensitization, most patients with a history of penicillin allergy can safely receive drug.
- Preventing kidney failure: Primary care physicians must intervene earlier
Five simple questions can help one to intervene early and effectively, using just a few minutes of an office visit.
- Practical tips for warfarin dosing and monitoring
Patients on warfarin walk a tightrope between bleeding and clotting—and a hundred things can tip the balance.
- Osteoporosis in men: Suspect secondary disease first
Osteoporosis is a disease not only of women. In men particularly, we need to seek an underlying cause.
- Isoflavones and the prevention and treatment of prostate disease: Is there a role?
Conclusive proof can only come from clinical trials.
- Microalbuminuria: Is it a valid predictor of cardiovascular risk?
Protein in the urine is bad, even in small amounts. The risks, possible mechanisms, and recommendations.
Mechanical treatment of heart failure: The growing role of LVADs and artificial heartsThe devices can keep a patient alive while waiting for a transplant, and they might allow a damaged heart to recover.
- Vertebral compression fractures: Manage aggressively to prevent sequelae
Advances in preventing and managing acute vertebral compression fractures can reduce their devastating impact, even in the face of an aging population.
- Challenges and choices in drug therapy for chronic pain
Chronic pain is different from acute pain, and its treatment is more challenging.
